Immunotherapy with a standardized Dermatophagoides pteronyssinus extract.

@inproceedings{Roches1996ImmunotherapyWA,
  title={Immunotherapy with a standardized Dermatophagoides pteronyssinus extract.},
  author={Anne Des Roches and Louis Paradis and Jalel Knani and Adan Hejjaoui and H. Dhivert and Pascal Chanez and J. T. Bousquet},
  year={1996}
}
  • Anne Des Roches, Louis Paradis, +4 authors J. T. Bousquet
  • Published 1996
  • Medicine
  • Specific immunotherapy (SIT) using a standardized mite extract is effective and safe when administered under optimal conditions. However, the duration of its effectiveness after cessation of treatment remains unknown. Forty asthmatic subjects who had received SIT with a standardized Dermatophagoides pteronyssinus (Der p) extract under the same protocol were studied. All had received SIT for a period of 12–96 months and were not receiving pharmacologic treatment. The FEV1 was within normal range… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 63 CITATIONS, ESTIMATED 72% COVERAGE

    Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite.

    VIEW 4 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol

    VIEW 1 EXCERPT
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Allergy and Sleep

    A critical appraisal on AIT in childhood asthma

    VIEW 1 EXCERPT
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    1997
    2019

    CITATION STATISTICS

    • 3 Highly Influenced Citations